Association of maternal air pollution exposure and infant lung function is modified by genetic propensity to oxidative stress
=============================================================================================================================

* Dwan Vilcins
* Wen Ray Lee
* Cindy Pham
* Sam Tanner
* Luke D. Knibbs
* Dave Burgner
* Tamara L Blake
* Toby Mansell
* Anne-Louise Ponsonby
* Peter D Sly
* Barwon Infant Study Investigator group

## Abstract

**Introduction** The association between air pollution and poor respiratory health outcomes is well established, however less is known about the biological mechanisms, especially in early life. Children are particularly at risk from air pollution, especially during the prenatal period as their organs and systems are still undergoing crucial development. Therefore, our study aims to investigate if maternal exposure to air pollution during pregnancy is associated with oxidative stress (OS) and inflammation in pregnancy or infant lung function at 4 weeks of age, and the extent to which the association is modified by an infant’s genetic risk of OS.

**Methods** The Barwon Infant Study (BIS) is a longitudinal study of Australian children from the region of Geelong, Victoria. A total of 314 infants had available lung function and maternal OS markers. Exposure to annual air pollutants (NO2 and PM2.5) were estimated using validated, satellite-based, land-use regression models. Infant lung function was measured by multiple-breath washout, and the ratio of peak tidal expiratory flow over expiratory time was calculated at 4 weeks of age. An inflammation biomarker, glycoprotein acetyls (GlycA), was measured in maternal (36 weeks) and cord blood, and oxidative stress (OS) biomarkers, 8-hydroxyguanine (8-OHGua) and 8-hydroxy-2’-deoxyguanosine (8-OHdG) were measured in maternal urine at 28 weeks. A genetic pathway score for OS (gPFSox) was calculated for each infant participant in the BIS cohort, and high risk defined as score >8. Linear regression was used to explore the association of maternal air pollution exposure with infant lung function, and potential modification by OS genotype was tested through use of interaction terms and other methods.

**Results** There was no evidence of a relationship between maternal exposure to air pollution and infant lung function in the whole population. We did not find an association between air pollution and GlycA or OS during pregnancy. We found evidence of an association between NO2 and lower in functional residual capacity (FRC) for children with a high genetic risk of OS (β=-5.3 mls, 95% CI (−9.3, -1.3), p=0.01). We also found that when NO2 was considered in tertiles, the highest tertile of NO2 was associated with increase in lung clearance index (LCI) (β=0.46 turnovers, (95% CI 0.10, 0.82), p=0.01) in children with a genetic propensity to OS.

**Conclusion** Our study found that high prenatal levels of exposure to ambient NO2 levels is associated with lower FRC and higher LCI in infants with a genetic propensity to oxidative stress. There was no relationship between maternal exposure to air pollution with maternal and cord blood inflammation or OS biomarkers.

Key words
*   Air pollutants
*   lung function
*   oxidative stress
*   environmental health
*   children’s health
*   nitrogen dioxide

## 1 Introduction

The association of air pollution with respiratory health outcomes is now well established in adult populations, but more work is required to assess risk to children’s health. Air pollution has been associated with increased mortality (1) and increased hospitalisations due to respiratory disease (2) across all stages of life. Children are particularly at risk from air pollution, including during the prenatal period. Maternal exposure to air pollution is associated with adverse child health outcomes, including some adverse respiratory outcomes (3-5), congenital heart defects (6), preterm birth (7) and low birthweight (8). Previous work has shown that maternal exposure to air pollution is associated with infant (4-5 weeks of age) respiratory changes such as poorer lung function (9) lower minute ventilation and higher exhaled nitric oxide (10). Previous evidence consistently demonstrates a strong association between air pollution with poor respiratory health outcomes. However, there are few studies that have investigated the underlying mechanisms of this association, especially in early life (10, 11). Oxidative stress (OS) and inflammation pathways are emerging as key mediators, where exposure to air pollution induces inflammation and/or OS, which then causes damage on a cellular level, leading to poorer lung health (11). The data exploring these processes as mediators between air pollution and children’s health outcomes are scarce. Previous work found higher levels NO2 exposure in the prenatal period was associated with an increase in exhaled nitric oxide in infants, which is indicative of airway inflammation (10). A prospective study of asthmatic children in Mexico City found that an OS biomarker, malondialdehyde, in expired breath condensate was associated with exposure to ozone, PM2.5, and presence of heavy vehicles, suggesting that children exposed to high levels of air pollution have higher OS responses (11). In a cross-sectional analysis of Mexican school children, exposure to air pollution increased circulating biomarkers of OS (in serum; conjugated dienes, lipo-hydroperoxides, malondialdehyde, protein carbonylation) in school aged children (7-12 years) (12). A case-control study of Hungarian children revealed an increased risk of infection-induced asthma exacerbation for those children who were more heavily exposed to traffic-related air pollution exposure and had polymorphisms in the NFE2L2 gene, which has a role in regulation of oxidative stress (13).

To the best of our knowledge, only two previous studies have explored the association of maternal air pollution exposure with lung function in infants, and neither have sought to test underlying biological pathways of this association. Further, we could not identify any previous studies that explored maternal exposure to air pollution during pregnancy and OS or inflammation biomarkers. To address this evidence gap, our study aims to investigate if maternal exposure to air pollution during pregnancy is associated with infant lung function at 4 weeks of age and the extent to which this association is modified by a child’s genetic risk of OS. Further, we seek to understand if air pollution exposure is associated with OS biomarkers in mothers, or an inflammation marker in maternal blood during pregnancy or cord blood at birth.

## 2 Methods

### 2.1 Cohort details

The Barwon Infant Study (BIS) is a longitudinal study of Australian children from the region of Geelong, Victoria. The cohort has several major objectives including BIS respiratory, which seeks to investigate factors influencing respiratory health in children. Women were recruited from two major hospitals in the Barwon region and eligible women were invited to participate in the study at a routine antenatal appointment occurring around 15 weeks of gestation. Recruitment occurred between 2010-2013, with ongoing 2-year follow up. A total of 1,064 women who delivered 1,074 infants (10 sets of twins) were enrolled into the study. Participants completed comprehensive questionnaires at 28 weeks antenatal, birth and 1 month of age, which was supplemented with a physical review at each time point. At the 1 month review, participants were invited to undergo multiple breath washout (MBW) testing. The 1 month review was completed by 982 infants and MBW testing was attempted in 570 infants whose parents consented to the test, did not have any respiratory illness, and fell asleep during the test attempt (14). Infants with two or more technically acceptable tests were included in this analysis (*n=*314). The sample size of infants with lung function and maternal OS markers was 257. The study was approved by the Barwon Health Human Research Ethics Committee (HREC 10/24) and written informed consent was obtained from the participating families. Further details on the cohort have been published previously (15).

### 2.2 Air pollutants

We estimated maternal prenatal air pollution exposure using two satellite-based, land-use regression models (Sat-LUR) (16) that we developed and validated and are described in previous studies (17) (18). The Sat-LURs were developed for annual mean concentrations of nitrogen dioxide (NO2) and particulate matter ≤ 2.5 μm (PM2.5). The indicative spatial resolution of the models is up to 100 m in urban areas and up to 500 m in rural and remote areas (19). NO2 is the most spatially heterogeneous component of traffic related air pollution (TRAP) and exhibits strong near-traffic gradients; it is therefore a frequently used proxy for TRAP mixtures. Both Sat-LUR models were developed with satellite, land use and other spatial predictors. The NO2 model captured between 66% and 81% of variability in measured annual NO2 concentrations, respectively, with RMSE of 1.4 to 2 ppb over the time span of the cohort. The PM2.5 model captured between 52% and 63% of variability in PM2.5, with an RMSE of 1 to 1.2 μg/m3 (20). Participant’s residential addresses during pregnancy were geocoded to 6 decimal places. These were matched with the air quality data to give estimates of PM2.5 and NO2 for each participant in the prenatal period, at birth and at 1 month of age. Where participants changed address between follow-ups, their estimated exposure at each property was averaged.

### 2.3 Infant lung function

Infant lung function was measured by multiple-breath washout (MBW) with sulphur hexafluoride (SF6) (14) at 4 weeks of age during natural sleep (21). MBW gives indices of lung size (functional residual capacity, FRC) and ventilation distribution (lung clearance index, LCI). LCI provides an early indication of airway obstruction. Tidal breathing was recorded prior to MBW and the ratio of peak tidal expiratory flow over expiratory time (tPTEF/tE) was calculated. A shortening of tPTEF/tE ratio has been used to indicate airway obstruction (22). Two records were excluded from the analysis on the basis of implausible lung function values (FRC >6 L; LCI <1 lung volume turnovers). As previously stated, there was *n*=314 children with data for FRC and LCI, however due to the nature of the test we had a slightly higher sample size for tPTEF/tE (*n*=355).

### 2.4 Inflammation

GlycA is a composite NMR metabolomic marker of glycosylated acute phase proteins (23). Previous work in this cohort have shown that GlycA is a superior measure of cumulative inflammation at a younger age than high-sensitivity C reactive protein (24, 25). GlycA (mmol/L) was measured in maternal (36 weeks) and cord serum (birth) by nuclear magnetic resonance (NMR) (Nightingale Health, Helsinki, Finland). We tested the associations of air pollution with both maternal GlycA during pregnancy and cord blood GlycA in this study.

### 2.5 Oxidative stress biomarkers and gene pathway function score

Maternal urinary samples at 36 weeks of gestation were collected and processed within 24 hours and stored at –80°C until analysis. Urinary OS biomarkers, 8-hydroxyguanine (8-OHGua) and 8-hydroxy-2’-deoxyguanosine (8-OHdG), were quantified using liquid chromatography-mass spectroscopy (LC-MS/MS) performed by the Australian National Phenome Centre (Perth, WA, Australia). Briefly, chromatographic separation was performed using an ExionLCTM system (SCIEX; Framingham, MA, USA), reversed-phase separation used a Kinetex C8 2.6 μm 2.1 × 150 mm column (Phenomenex; Lane Cove West, NSW, Australia) at 40°C, and mass spectrometry detection with electrospray ionisation was evaluated with a QTRAP 6500+ system (SCIEX; Framingham, MA, USA). The lower limit of quantification (LOQ) was 1.5 ng/mL for 8-OHGua and 0.9 ng/mL for 8-OHdG (Cayman Chemical; Ann Arbour, MI, USA). Data acquisition was performed using Analyst®1.7.1 and analysed using SCIEX OS Analytics 1.7.0 software (SCIEX; Framingham, MA, USA). The inter-assay coefficient of variation was low (<10%) for the quality control measures. Levels of OS biomarkers below the LOQ were imputed as the LOQ divided by the square root of 2 (26). Prior to analysis, the urinary OS biomarkers measures were pre-processed to correct for i) time interval between urine collection, processing and storage by fitting a linear model and retaining the residuals (27); ii) batch effects (28); and iii) urine dilution using specific gravity (29). Given the left-skewed distribution, a base-2 log transformation was applied to all OS biomarkers for subsequent analyses (30).

A genetic pathway score for OS (gPFSox) has been previously developed for this cohort (31). In brief, DNA samples were extracted from cord blood and infant 12-month whole blood, and whole-genome genotyping was performed. Twelve genes (four pro-oxidant, eight antioxidant) in a minimal OS pathway were identified. For each of these genes, single-nucleotide genetic polymorphisms (SNPs) linked to gene activity were identified using the GTEx database (32, 33) and the SNP most strongly associated with expression was chosen (non-tissue specific). After assessing the SNPs’ effect on each identified gene (increased or decreased expression), and the impact of each gene on OS (pro- or antioxidant), a cumulative score was calculated for each participant in the BIS. This score reflects the number of pro-oxidant alleles each individual carries for the OS response pathway, and therefore their propensity towards OS (32). The score was divided by 2 to give a score range of 0-12, and participants with a gPFSox of ≥ 8 (which represented the top 20%) were classified as having a high genetic risk of OS.

### 2.6 Covariates

Several covariates were considered for inclusion in the adjusted model. A directed acyclic graph (DAG) was created based on previous literature and expert knowledge (Supplementary materials, Figure S1). Several of the variables identified had many records with missing data, and multiple imputation was not appropriate given the volume of missing data. Therefore, a minimal set of confounders were included in the models. Postnatal age at lung function was tested as a covariate but was not found to be important in this cohort. Variable selection was predominately decided by the process of the DAG and expert knowledge by the respiratory scientists and physicians on our team, however a formal stepwise regression was performed to test the variable set (including those variables with missing data) which found AIC and R2 were better in our selected covariate set, and plots of the residuals showed a better fit when variables with a high volume of missingness were removed. The final model included maternal pre-pregnancy body mass index (BMI), maternal age, maternal prenatal smoking (any vs none), child’s sex and birthweight.

### 2.7 Statistical analysis

Variables were described using histograms and basic statistical summaries. Relationships between variables were explored through plotting and correlation analysis using the Pearson product-moment correlation coefficient. Linear regression was used to explore the association of maternal air pollution exposure with infant lung function at 4 weeks of age, OS biomarkers during pregnancy and inflammation biomarkers during pregnancy (mothers) and from cord blood (child). Modification of the relationship between air pollutants and lung function by presence of an OS genotype in the child was explored through use of interaction terms and stratified analysis. PM2.5 and NO2 were considered as continuous variables for the primary analyses and results are presented for an IQR increase in pollutant. All analysis was performed in R version 4.2.1, 2022 (R Core Team).

#### 2.7.1 Sensitivity analyses

We performed several sensitivity analyses. Socioeconomic status (SES) was considered as a potential confounder. It has previously been shown in this cohort that inflammation partially mediates the relationship between socioeconomic disadvantage and emotional and behavioural problems in children (25). Education is the socioeconomic indicator recommended by the Organisation for Economic Co-operation and Development for reporting and monitoring socioeconomic inequalities as it is reported with reasonable reliability, can be harmonized across cohorts and countries, generally has few missing data, is relatively stable across adulthood, and is less subject to reverse causality than measures such as income (34, 35). In BIS, maternal education was self-reported in pregnancy in the following categories: < year 10, year 10, year 12, trade, certificate or diploma, bachelor degree or postgraduate degree. Multiplicative interaction terms were added for air pollution and maternal smoking in FRC models. PM2.5 and NO2 were considered as tertiles, instead of as continuous exposures, to test for non-linearity. Models testing tertiles compared medium to low exposure, and high to low exposure. The effect of air pollution exposure at birth and 1 month of age on lung function was also tested. Lastly, we investigated models that included a child’s exposure to environmental tobacco smoke at 1 month of age as direct exposure to smoke in the home can affect a child’s lung function (36).

## 3 Results

### 3.1 Descriptive results

There were 314 children who had lung function testing conducted at 4 weeks of age and met all the criteria. Of these 51% were male. Maternal smoking during pregnancy was present for 15.6% of children. Mean maternal exposure to PM2.5 was 7.5 μg/m3, (min=4.9, max=9.9). Mean maternal NO2 was 5.58 ppb (min=1.9, max=15.4). Mean FRC in mL/kg was 18.5, mean LCI was 6.79 lung turnover volumes and tPTEF/tE was 0.37. The cohort summary is presented in Table 1 and Supplementary Table 1.

View this table:
[Table 1:](http://medrxiv.org/content/early/2023/10/13/2023.10.13.23296994/T1)

Table 1: Summary of Barwon Infant Study children and mothers, who completed lung function testing at 4 weeks of age (n=314).

### 3.2 Air pollution and infant lung function, and modification by genetic propensity to oxidative stress

Table 2 demonstrates the association between air pollution and infant lung function, in the whole population, as well as in children with a genetic propensity to oxidative stress. There was no evidence of a relationship between maternal exposure to air pollution during pregnancy and infant lung function at 4 weeks of age. Maternal exposure to PM2.5 was not associated with LCI (β=-0.03 turnovers, 95% CI (−0.09, 0.03), p = 0.34), FRC (β=1.3 mls, 95% CI (−0.9, 3.5), p=0.23) or tPTEF/tE (β=0.003, 95% CI (−0.010, 0.017), p=0.65) at 4 weeks of age in adjusted models. Similarly, maternal exposure to NO2 was not associated with LCI (β=0.01 turnovers, 95% CI (−0.04, 0.06), p=0.68), FRC (β=-0.7 mls, 95% CI (−2.5, 1.1), p=0.46) or tPTEF/tE (β=0.003, 95% CI (−0.009, 0.015), p=0.63) at 4 weeks of age in adjusted models.

View this table:
[Table 2:](http://medrxiv.org/content/early/2023/10/13/2023.10.13.23296994/T2)

Table 2: Results of linear regression models of maternal exposure to air pollution (IQR increase) and infant lung function at 4 weeks of age in the Barwon Infant Study

The relationship between maternal air pollution exposure and lung function was explored in the context of a child’s genetic risk for OS. We found evidence of an association between NO2 and reductions in lung function for those children with a gPFSox indicating a high risk of OS. For an IQR increase (ppb) of NO2 there was a 5.3 mL decrease in FRC at 4 weeks of age (β=-5.3 mls, 95% CI (−9.3, -1.3), p=0.01). An IQR increase in maternal NO2 was not associated with LCI (β=0.08 turnovers, 95% CI (−0.04, 0.20), p=0.18). However, there is a potential for a threshold response.

We did not find a relationship between maternal exposure to PM2.5 and either FRC (β=-3.4 mls, 95% CI (−8.4, 1.5), p=0.18) or LCI (β=0.03 turnovers, 95% CI (−0.11, 0.17), p=0.67) LCI in children at high risk of OS. This did not change when using exposure in tertiles (see table S8 in table). Finally, there was no association with either PM2.5 (β -0.01, 95% CI (−0.04, 0.02), p=0.49) or NO2 (β 0.01, 95% CI (−0.03, 0.03), p=0.99) and tPTEF/tE at 4 weeks of age, in children at higher risk of OS.

### 3.3 Air pollution and inflammation

Table 3 shows the estimated effect of air pollution on GlycA, a marker of chronic inflammation, in mothers and in cord blood. There was no relationship between maternal exposure to PM2.5 (β=-0.01 mmol/l, 95% CI (−0.02, 0.01), p=0.50) or NO2 (β=0.003 mmol/l, 95% CI (−0.012, 0.017), p=0.73) and GlycA in maternal blood in fully adjusted models. Further, there was no relationship between maternal exposure to PM2.5 (β=0.01 mmol/l, 95% CI (−0.02, 0.04), p=0.56) or NO2 (β=0.05 mmol/l, 95% CI (−0.017, 0.028), p=0.64) and GlycA in cord blood in fully adjusted models.

View this table:
[Table 3:](http://medrxiv.org/content/early/2023/10/13/2023.10.13.23296994/T3)

Table 3: Results of linear regression models of maternal exposure to air pollution and maternal and child oxidative stress biomarkers and inflammation in the Barwon Infant Study

### 3.4 Air pollution and oxidative stress

Table 3 demonstrates the association between air pollution and maternal oxidative stress. There was no relationship between maternal exposure to air pollution and biomarkers for OS during pregnancy or in cord blood. There was no association between PM2.5 and urinary 8-OHdG (β=0.08 ng/mL, 95% CI -0.07, 0.21, p=0.33) or NO2 (β=0.01 ng/mL, 95% CI (−0.12, 0.13), p=0.93) in fully adjusted models. The same was true of urinary 8-OHGua, which was not associated with PM2.5 (β=0.02 ng/mL, 95% CI (−0.16, 0.21), p=0.81) nor NO2 (β=0.03 ng/mL, 95% CI (−0.13, 0.19), p=0.69) in adjusted models.

### 3.5 Sensitivity analysis

Several sensitivity analyses were performed: using a child’s own passive smoking exposure, instead of maternal smoking, as a covariate; an interaction term between air pollution and maternal smoking; air pollutants as tertiles; the effect of SES; and a child’s direct exposure to air pollution and lung function. There were no significant associations in any of our sensitivity analyses and model fit was not improved compared with the main models, with the exception of high exposure to NO2 and lung function measures. When including NO2 in tertiles, the highest tertile of NO2 was associated with differences in both FRC (β=-13.1 mls, 95% CI (−26.1, -0.1), p=0.05) and LCI (β=0.46 turnovers, (95% CI 0.10, 0.82), p=0.01) in children with a genetic propensity to oxidative stress (see table S7 in supplement, difference in effect from children at low risk of OS is *p=*0.02 and *p=*0.007, respectively). (See supplementary materials). A sensitivity analysis was performed using an interaction term between a child’s gPFSox and maternal air pollution for each lung function outcome, but none were significant (data not shown).

## 4 Discussion

Our study found that high levels of exposure to NO2 is associated with lower FRC and higher LCI in infants with a genetic propensity to oxidative stress. There was no relationship between maternal exposure to air pollution and infant lung function, in the whole population. We found no overall association between air pollution and either maternal or cord blood inflammation biomarkers. Our results are largely in keeping with those of Latzin et al. (10), who did not find an association with MBW parameters, although they did report an association between PM10 and tidal breathing flows. We did not have data on PM10 to assess the effect of the larger size fraction in our cohort. Decrue et al (9) reported an association between minute ventilation and maternal exposure to PM10 and NO2 in the second trimester, especially in preterm infants, however they did not find a relationship with tPTEF/tE and either air pollutant. In our study, there were only 15 participants born preterm (< 37 weeks gestational age) with lung function data, and univariate analysis did not find an association between air pollution exposure in the antenatal period and lung function at 4 weeks in preterm infants (data not shown).

The lack of association between air pollution and OS was surprising. Our sample size is modest for testing associations with air pollution, which tend to have small effect estimates (37), which is an issue in post hoc analysis where the cohort is powered for clinical outcomes. The Barwon Infant Study was designed to minimise participant burden while achieving deep phenotyping, but it has previously being recognised that this may come at a cost of statistical power, especially for uncommon outcomes and those with small effect sizes (15). It has previously been found that circulating biomarkers are less sensitive to air pollution exposure than more localised lung measures. Zhang et al (38) found an association between various air pollutants and malondialdehyde in expired breath condensate, however they found little relationship between air pollutants and oxidised low density lipoprotein or interleukin-6.

Future research on this topic should focus on respiratory-specific markers of oxidation, such as malondialdehyde (11, 12) or glutathione sulfonamide (39). Previous work in this cohort found that a high risk OS genotype combined with higher exposure to phthalates in utero was associated with an elevated risk of adverse neurodevelopmental outcomes when compared with children who had a genotype not at increased risk of OS (40). It is possible that lung function development is protecting by the buffering and defence mechanisms occurring in utero, especially the protection offered by the placenta. There is a well developed body of literature and meta-analysis showing that endocrine disrupting chemicals cross the placenta, and affect the development of key systems (41, 42). However, it is less clear how air pollutants influence the development of children, and which systems are vulnerable. This is an area that requires more research. Lastly, we need to consider the level of air pollution exposure in this cohort, and whether the pollution levels are too low to impact on lung development. This is unlikely given the previous studies were also conducted in communities with historically good air quality. We hypothesized that children with a genotype predisposing them to a higher risk of OS would have a stronger negative association between maternal air pollution exposure and infant lung function, which was true for NO2. This indicates that examining the impact of air pollution on those with genetic vulnerability such as those with a low genetic antioxidant capacity is informative.

The Barwon Infant Study is a unique and data rich cohort, that affords our study several methodological strengths. Lung function testing was performed in non-sedated infants and followed international guidelines (22). Participants were recruited prospectively in the prenatal period from all eligible members of the population, and therefore there in no selection bias in regard to exposure or outcome. Our air pollution model is externally validated and has been used in previous studies (17, 18). Urinary oxidative stress biomarkers were measured using the ‘gold-standard’ approach of LC-MS/MS and pre-processed to reduce the number of variables required in the model. However, limitations remain. The sample size is modest, as discussed earlier. Not all parents consented to lung function testing, and only 55% of infants who attempted lung function returned acceptable and reproducible results. Our air pollution model is limited to annual averages, which does not allow us to measure short-term temporal changes or trimester specific effects. We only have a single time point for the OS biomarkers. We did not have OS biomarkers in the infants. Lastly, our sample was not large enough for sex-specific analysis and may be subject to unmeasured confounding.

## 5 Conclusion

Our study finds no association between maternal exposure to PM2.5 or NO2 in the prenatal period and infant lung function at four weeks of age, with the exception of NO2 for children at higher genetic risk of OS. Further, we did not find an association between maternal exposure to air pollution and OS biomarkers in maternal blood or cord blood.

## Supporting information

Supplement [[supplements/296994_file02.pdf]](pending:yes)

## Data Availability

All data produced in the present study are only available under strict approval conditions for approved research projects from the Barwon Infant Study

## Acknowledgements

The authors thank the *Barwon Infant Study* participants for their valuable contribution. The establishment work and infrastructure for the BIS was provided by the Murdoch Children’s Research Institute, Deakin University and Barwon Health. Subsequent funding was secured from the National Health and Medical Research Council of Australia, The Jack Brockhoff Foundation, the Scobie Trust, the Shane O’Brien Memorial Asthma Foundation, the Our Women’s Our Children’s FundRaising Committee Barwon Health, The Shepherd Foundation, the Rotary Club of Geelong, the Ilhan Food Allergy Foundation, GMHBA Limited and the Percy Baxter Charitable Trust, Perpetual Trustees, and the Minderoo Foundation. In-kind support was provided by the Cotton On Foundation and CreativeForce. Research at Murdoch Children’s Research Institute is supported by the Victorian Government’s Operational Infrastructure Support Program. C Pham is supported by a Melbourne Children’s Campus LifeCourse PhD Support Program scholarship, funded by Royal Children’s Hospital Foundation grant number 2018-984. This work was also supported by NHMRC, Australia Investigator Grants [APP1197234 to AL Ponsonby]. We thank Terry Dwyer for his role in the original BIS Steering Committee. The BIS Investigator Group consists of John Carlin, Mimi Tang, Len Harrison, Fiona Collier, Amy Loughman, Sarath Ranganathan and Lawrence Gray. D Vilcins was supported by the Louisiana State University Superfund Research program and the National Institute Of Environmental Health Sciences of the National Institutes of Health under Award Number P42ES013648. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

D Burgner is supported by a National Health and Medical Research Council (Australia) Investigator Grant APP1175744. Research at Murdoch Children’s Research Institute is supported by the Victorian Government’s Operational Infrastructure Support Program.

*   Received October 13, 2023.
*   Revision received October 13, 2023.
*   Accepted October 13, 2023.


*   © 2023, Posted by Cold Spring Harbor Laboratory

The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.

## References

1.  1.Chen J, Hoek G. Long-term exposure to PM and all-cause and cause-specific mortality: A systematic review and meta-analysis. Environment International. 2020;143:105974.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.envint.2020.105974&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32703584&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F10%2F13%2F2023.10.13.23296994.atom) 

2.  2.Slama A, Sliwczynski A, Woznica J, Zdrolik M, Wisnicki B, Kubajek J, et al. Impact of air pollution on hospital admissions with a focus on respiratory diseases: a time-series multi-city analysis. Environmental Science and Pollution Research. 2019;26(17):16998–7009.
    
    

3.  3.Gascon M, Vrijheid M, Nieuwenhuijsen MM. The Built Environment and Child Health: An Overview of Current Evidence. Current Environmental Health Reports. 2016;3(3):250–7.
    
    

4.  4.Dick S, Friend A, Dynes K, AlKandari F, Doust E, Cowie H, et al. A systematic review of associations between environmental exposures and development of asthma in children aged up to 9 years. BMJ Open. 2014;4(11):e006554.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYm1qb3BlbiI7czo1OiJyZXNpZCI7czoxMjoiNC8xMS9lMDA2NTU0IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjMvMTAvMTMvMjAyMy4xMC4xMy4yMzI5Njk5NC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

5.  5.Schraufnagel DE, Balmes JR, Cowl CT, De Matteis S, Jung SH, Mortimer K, et al. Air Pollution and Noncommunicable Diseases: A Review by the Forum of International Respiratory Societies’ Environmental Committee, Part 2: Air Pollution and Organ Systems. Chest. 2019;155(2):417–26.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.chest.2018.10.041&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=30419237&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F10%2F13%2F2023.10.13.23296994.atom) 

6.  6.Hu C-Y, Huang K, Fang Y, Yang X-J, Ding K, Jiang W, et al. Maternal air pollution exposure and congenital heart defects in offspring: A systematic review and meta-analysis. Chemosphere. 2020;253:126668.
    
    

7.  7.Han Y, Jiang P, Dong T, Ding X, Chen T, Villanger GD, et al. Maternal air pollution exposure and preterm birth in Wuxi, China: Effect modification by maternal age. Ecotoxicology and Environmental Safety. 2018;157:457–62.
    
    

8.  8.Dadvand P, Parker J, Bell ML, Bonzini M, Brauer M, Darrow LA, et al. Maternal Exposure to Particulate Air Pollution and Term Birth Weight: A Multi-Country Evaluation of Effect and Heterogeneity. Environmental health perspectives. 2013;121(3):267–373.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1289/ehp.1205575&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=23384584&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F10%2F13%2F2023.10.13.23296994.atom) 

9.  9.Decrue F, Gorlanova O, Salem Y, Vienneau D,  Hoogh Kd, Gisler A, et al. Increased Impact of Air Pollution on Lung Function in Preterm versus Term Infants: The BILD Study. American journal of respiratory and critical care medicine. 2022;205(1):99–107.
    
    

10. 10.Latzin P, Röösli M, Huss A, Kuehni CE, Frey U. Air pollution during pregnancy and lung function in newborns: a birth cohort study. European Respiratory Journal. 2009;33(3):594–603.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiZXJqIjtzOjU6InJlc2lkIjtzOjg6IjMzLzMvNTk0IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjMvMTAvMTMvMjAyMy4xMC4xMy4yMzI5Njk5NC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

11. 11.Romieu I, Barraza-Villarreal A, Escamilla-Nunez C, Almstrand A, Diaz-Sanchez D, Sly PD, et al. Exhaled breath malondialdehyde as a marker of effect of exposure to air pollution in children with asthma. J Allergy Clin Immunol. 2008;121(4):903–9.e6.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jaci.2007.12.004&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=18234317&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F10%2F13%2F2023.10.13.23296994.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000254884000014&link_type=ISI) 

12. 12.Romero-Calderón AT, Moreno-Macías H, Manrique-Moreno JDF, Riojas-Rodríguez H, Torres-Ramos YD, Montoya-Estrada A, et al. Oxidative stress, lung function and exposure to air pollutants in Mexican schoolchildren with and without asthma. Salud Publica de Mexico. 2017;59(6):630–8.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F10%2F13%2F2023.10.13.23296994.atom) 

13. 13.Ungvari I, Hadadi E, Virag V, Nagy A, Kiss A, Kalmar A, et al. Relationship between air pollution, NFE2L2 gene polymorphisms and childhood asthma in a Hungarian population. Journal of community genetics. 2012;3(1):25–33.
    
    

14. 14.Vukcevic D, Carlin JB, King L, Hall GL, Ponsonby AL, Sly PD, et al. The influence of sighing respirations on infant lung function measured using multiple breath washout gas mixing techniques. Physiol Rep. 2015;3:e12347.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MTE6InBoeXNyZXBvcnRzIjtzOjU6InJlc2lkIjtzOjEwOiIzLzQvZTEyMzQ3IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjMvMTAvMTMvMjAyMy4xMC4xMy4yMzI5Njk5NC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

15. 15.Vuillermin P, Saffery R, Allen KJ, Carlin JB, Tang ML, Ranganathan S, et al. Cohort Profile: The Barwon Infant Study. International journal of epidemiology. 2015;44(4):1148–60.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/ije/dyv026&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=25829362&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F10%2F13%2F2023.10.13.23296994.atom) 

16. 16.Knibbs LD, Hewson MG, Bechle MJ, Marshall JD, Barnett AA. A national satellite-based land-use regression model for air pollution exposure assessment in Australia. Environmental research. 2014;135:204–11.
    
    

17. 17.Bowatte G, Erbas B, Lodge CJ, Knibbs LD, Gurrin LC, Marks GB, et al. Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle age. Eur Respir J. 2017;50(4).
    
    

18. 18.Knibbs LD, Coorey CP, Bechle MJ, Cowie CT, Dirgawati M, Heyworth JS, et al. Independent Validation of National Satellite-Based Land-Use Regression Models for Nitrogen Dioxide Using Passive Samplers. Environmental science & technology. 2016;50(22):12331–8.
    
    

19. 19.Ahmed SM, Mishra GD, Moss KM, Yang IA, Lycett K, Knibbs LL. Maternal and Childhood Ambient Air Pollution Exposure and Mental Health Symptoms and Psychomotor Development in Children: An Australian Population-Based Longitudinal Study. Environment International. 2022;158:107003.
    
    

20. 20.Knibbs LD, van Donkelaar A, Martin RV, Bechle MJ, Brauer M, Cohen DD, et al. Satellite-Based Land-Use Regression for Continental-Scale Long-Term Ambient PM(2.5) Exposure Assessment in Australia. Environmental science & technology. 2018;52(21):12445–55.
    
    

21. 21.Czovek D, Shackleton C, Hantos Z, Taylor K, Kumar A, Chacko A, et al. Tidal changes in respiratory resistance are sensitive indicators of airway obstruction in children. Thorax. 2016;71:907–15.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToidGhvcmF4am5sIjtzOjU6InJlc2lkIjtzOjk6IjcxLzEwLzkwNyI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIzLzEwLzEzLzIwMjMuMTAuMTMuMjMyOTY5OTQuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

22. 22.Stocks J, Sly P, Tepper R, Morgan W, editors. Infant Respiratory Function Testing. New York: John Wiley & Sons; 1996.
    
    

23. 23.Otvos JD, Shalaurova I, Wolak-Dinsmore J, Connelly MA, Mackey RH, Stein JH, et al. GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation. Clin Chem. 2015;61(5):714–23.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6ODoiY2xpbmNoZW0iO3M6NToicmVzaWQiO3M6ODoiNjEvNS83MTQiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMy8xMC8xMy8yMDIzLjEwLjEzLjIzMjk2OTk0LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

24. 24.Collier F, Ellul S, Juonala M, Ponsonby A-L, Vuillermin P, Saffery R, et al. Glycoprotein acetyls (GlycA) at 12 months are associated with high-sensitivity C-reactive protein and early life inflammatory immune measures. Pediatric Research. 2019;85(5):584–5.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/s41390-019-0307-x&link_type=DOI) 

25. 25.Pham C, Bekkering S, O’Hely M, Burgner D, Thomson S, Vuillermin P, et al. Infant inflammation predicts childhood emotional and behavioral problems and partially mediates socioeconomic disadvantage. Brain Behav Immun. 2022;104:83–94.
    
    

26. 26.Hornung RW, Reed LL. Estimation of Average Concentration in the Presence of Nondetectable Values. Applied Occupational and Environmental Hygiene. 1990;5(1):46–51.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/1047322X.1990.10389587&link_type=DOI) 

27. 27.Mortamais M, Chevrier C, Philippat C, Petit C, Calafat AM, Ye X, et al. Correcting for the influence of sampling conditions on biomarkers of exposure to phenols and phthalates: a 2-step standardization method based on regression residuals. Environmental Health. 2012;11(1):29.
    
    

28. 28.Engel SM, Villanger GD, Nethery RC, Thomsen C, Sakhi AK, Drover SSM, et al. Prenatal Phthalates, Maternal Thyroid Function, and Risk of Attention-Deficit Hyperactivity Disorder in the Norwegian Mother and Child Cohort. Environmental Health Perspectives. 2018;126(5):057004.
    
    

29. 29.Levine L, Fahy JJ. Evaluation of urinary lead excretion for persons at work. J Ind Hyg Toxicol. 1946;28:98.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20982155&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F10%2F13%2F2023.10.13.23296994.atom) 

30. 30.Pham C, Thomson S, Chin S-T, Vuillermin P, O’Hely M, Burgner D, et al. Maternal oxidative stress during pregnancy associated with emotional and behavioural problems in early childhood: Implications for fetal programming. (accepted in Molecular Psychiatry). 2023.
    
    

31. 31.Tanner S, Thomson S, Drummond K, O’Hely M, Symeonides C, Mansell T, et al. A Pathway-Based Genetic Score for Oxidative Stress: An Indicator of Host Vulnerability to Phthalate-Associated Adverse Neurodevelopment. Antioxidants. 2022;11(4):659.
    
    

32. 32.Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, et al. The genotypetissue expression (GTEx) project. Nature genetics. 2013;45(6):580–5.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/ng.2653&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=23715323&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F10%2F13%2F2023.10.13.23296994.atom) 

33. 33.GTEx Portal. [Available from: [https://gtexportal.org/home/](https://gtexportal.org/home/).
    
    

34. 34.Duncan GJ, Daly MC, McDonough P, Williams DD. Optimal indicators of socioeconomic status for health research. American journal of public health. 2002;92(7):1151–7.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2105/AJPH.92.7.1151&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=12084700&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F10%2F13%2F2023.10.13.23296994.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000176521400034&link_type=ISI) 

35. 35.Mackenbach J, Menvielle G, Jasilionis D, de Gelder R. Measuring educational inequalities in mortality statistics. 2015.
    
    

36. 36.Carlsen K-H, Carlsen KCL. Respiratory effects of tobacco smoking on infants and young children.Paediatric Respiratory Reviews. 2008;9(1):11–20.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.prrv.2007.11.007&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=18280975&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F10%2F13%2F2023.10.13.23296994.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000254172500003&link_type=ISI) 

37. 37.Verbeek JH, Whaley P, Morgan RL, Taylor KW, Rooney AA, Schwingshackl L, et al. An approach to quantifying the potential importance of residual confounding in systematic reviews of observational studies: A GRADE concept paper. Environment International. 2021;157:106868.
    
    

38. 38.Zhang X, Staimer N, Gillen DL, Tjoa T, Schauer JJ, Shafer MM, et al. Associations of oxidative stress and inflammatory biomarkers with chemically-characterized air pollutant exposures in an elderly cohort. Environmental research. 2016;150:306–19.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F10%2F13%2F2023.10.13.23296994.atom) 

39. 39.Dickerhof N, Turner R, Khalilova I, Fantino E, Sly PD, Kettle AA. Oxidized glutathione and uric acid as biomarkers of early cystic fibrosis lung disease. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 2017;16(2):214–21.
    
    

40. 40.Ponsonby A-L, Symeonides C, Saffery R, Mueller JF, O’Hely M, Sly PD, et al. Prenatal phthalate exposure, oxidative stress-related genetic vulnerability and early life neurodevelopment: A birth cohort study. Neurotoxicology. 2020;80:20–8.
    
    

41. 41.Tang Z-R, Xu X-L, Deng S-L, Lian Z-X, Yu K. Oestrogenic Endocrine Disruptors in the Placenta and the Fetus. Int J Mol Sci. 2020;21(4):1519.
    
    

42. 42.Zhao X, Peng S, Xiang Y, Yang Y, Li J, Shan Z, et al. Correlation between Prenatal Exposure to Polybrominated Diphenyl Ethers (PBDEs) and Infant Birth Outcomes: A Meta-Analysis and an Experimental Study. International journal of environmental research and public health [Internet]. 2017; 14(3).